JAMES H. WELCH
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
EXECUTIVE OFFICER
ADRIAN ADAMS, RICHARD AFABLE, VINCENT ANGOTTI, VINCENT J ANGOTTI, VINCENT J. ANGOTTI, RAFFI ASADORIAN, SHAKIL ASLAM, MARINA BOZILENKO, JILL BROADFOOT, ANIL DASU, BADRI DASU, BADRI N. DASU, BADRI P DASU, MARK EDWARDS, LARRY HAMEL, STEPHEN HOFFMAN, STEPHEN J HOFFMAN, STEPHEN J. HOFFMAN, ABHINAV JAIN, LINDA JUDGE, CARTER KING, RICHARD KING, HAMEL G. LAWRENCE, GUY NOHRA, PAMELA PALMER, PAMELA P PALMER, PAMELA P. PALMER, HOWARD ROSEN, HOWARD B ROSEN, HOWARD B. ROSEN, HOWIE ROSEN, THOMAS SCHRECK, THOMAS A SCHRECK, STEVE SULLIVAN, MARK WAN, MARK B WEEKS, JAMES WELCH
EXECUTIVE OFFICER
GREGG ALTON, FOUAD AZZAM, CHARLES BRAMLAGE, KENNETH R. CHIEN, GRAHAM COOPER, DAVID A. CORY, BARBARA DALTON, THOMAS J. DIETZ, EDGAR G. ENGLEMAN, ANTHONY B. EVNIN, TODD FOLEY, JOSHUA FUNDER, JEFFREY S. GLENN, NINA KJELLSON, JOHAN KORDEL, REBECQUE LABA, EDUARDO BRUNO MARTINS, MICHAEL NARACHI, DANIEL OMSTEAD, JOANNE QUAN, ANDREW E. SENYEI, JAMES P. SHAFFER, LAUREN SILVERMAN, ASISH XAVIER, KRISZTINA ZSEBO
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2016-04-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2011-06-29

